FdaApplication
NDA 214231
Identifiers
- fda_app_no: NDA214231
Properties
| Property | Value |
|---|---|
| applicant_name | ZEALAND PHARMA US INC |
| application_type | NDA |
| approval_date | 2021-03-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZEGALOGUE | DASIGLUCAGON HYDROCHLORIDE | EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML) | SOLUTION;SUBCUTANEOUS |
| ZEGALOGUE (AUTOINJECTOR) | DASIGLUCAGON HYDROCHLORIDE | EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML) | SOLUTION;SUBCUTANEOUS |
2 products